Brief: BioLife Solutions Q3 Revenue USD 19 Million Vs. IBES Estimate USD 25.5 Million
12/11/2024 21:06
Nov 12 (Reuters) - BioLife Solutions Q3 gross margin 51%. * Q3 adjusted gross margin 54% * outlook FY revenue USD 98-100 million
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary